about
Phage therapy: concept to cureBacteriophages and their implications on future biotechnology: a reviewBacteriophage T4 GenomeNatural solution to antibiotic resistance: bacteriophages 'The Living Drugs'Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound modelExperimental phage therapy against Staphylococcus aureus in miceBarriers to coliphage infection of commensal intestinal flora of laboratory mice.Dynamics of success and failure in phage and antibiotic therapy in experimental infectionsNew insights into the possible role of bacteriophages in host defense and diseaseBacteriophage Procurement for Therapeutic PurposesInsights into Bacteriophage Application in Controlling Vibrio SpeciesGenetically Engineered Phages: a Review of Advances over the Last DecadeThe effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulationHuman microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approachesInvestigational drugs to treat methicillin-resistant Staphylococcus aureusPhage therapy of pulmonary infectionsBeyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold.Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current statusPhage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa InfectionsMasquerading microbial pathogens: capsular polysaccharides mimic host-tissue moleculesCoordinated DNA Replication by the Bacteriophage T4 ReplisomeBacteriophage remediation of bacterial pathogens in aquaculture: a review of the technologySynthetic biology of antimicrobial discoveryEscherichia coli in Europe: an overviewSubdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters.Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting DiseasesWhat's new in multidrug-resistant pathogens in the ICU?Bacteriophages and phage-derived proteins--application approachesMethicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odysseyMycobacteriophage and their application to disease controlBacteriophages for managing Shigella in various clinical and non-clinical settingswksl3, a New biocontrol agent for Salmonella enterica serovars enteritidis and typhimurium in foods: characterization, application, sequence analysis, and oral acute toxicity studyCharacterization and comparative genomic analysis of a novel bacteriophage, SFP10, simultaneously inhibiting both Salmonella enterica and Escherichia coli O157:H7Characterization of extended-host-range pseudo-T-even bacteriophage Kpp95 isolated on Klebsiella pneumoniaeGenetic evidence for the involvement of the S-layer protein gene sap and the sporulation genes spo0A, spo0B, and spo0F in Phage AP50c infection of Bacillus anthracisIsolation and characterization of φkm18p, a novel lytic phage with therapeutic potential against extensively drug resistant Acinetobacter baumanniiSynergistic action of gentamicin and bacteriophage in a continuous culture population of Staphylococcus aureusStrain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of InfectionApplication of Bacteriophage-containing Aerosol against Nosocomial Transmission of Carbapenem-Resistant Acinetobacter baumannii in an Intensive Care UnitWhat contemporary viruses tell us about evolution: a personal view
P2860
Q21131139-87DE3035-81CA-4AFF-A178-6409291945CAQ21245088-D67C816E-DE63-4ACB-B56B-8A515C0CDAA4Q22061798-53EF9BD5-A9AA-4E27-8E67-431CC124EA09Q24563742-35A92EDC-3F86-46C1-8CD7-1DC4BB8160EBQ24673374-B805062A-C3F7-484F-B7A1-63C6FDB262CEQ24685170-FA79572A-AF7A-4746-B0B0-C4CC9817189CQ24802520-9FD49E67-67F6-445A-B9C2-FEB11ED2B6BCQ24803578-8EE64D43-8626-48CD-A180-9CE4BB165143Q24804005-AE054D9A-DC6A-4462-9C34-F6BBCEA3677DQ26738479-A97AFE02-1A08-4AEF-A16A-D334169AFEBCQ26739744-461127AF-551A-4278-9C70-9CE5C3F31AF7Q26744156-D58DBD74-924D-4420-8558-4E6FC4C62B40Q26748672-327D0CC0-72AA-4373-B462-F3B88568343EQ26779242-37891A70-81AF-4DC6-AA88-07A6F8BB42FBQ26780246-12CEA722-4E17-4037-A45F-434A9B3517DEQ26781119-07C25C88-6AFB-48F1-A377-2A88BD64FAC7Q26795483-B6834057-BFA9-4C29-A208-939E5964E7C5Q26799417-F41E8832-507B-4CB6-919F-C4C10CBC5DA6Q26823401-F3BFDA4D-EBC1-45FE-B252-0F42D79B2FAFQ26865784-814C4D16-3103-4302-8826-B69C69386985Q26991929-5FA09DFA-75D3-4957-BA46-37960E571B21Q26998710-560609D1-509D-43E5-AAAB-7771BAAE323BQ27001264-8D0F246D-700F-470E-8B05-DEEFDCFDC2C5Q27015697-2083D8E1-147E-48FD-BE14-4051C961552FQ27322154-9253B9EE-D3F1-4588-BA47-FDEDDB498DE0Q28069939-FB837432-B693-475C-9E06-AD50D7A0FEA8Q28071346-EA406F64-5D5F-4476-A5BC-75898C06FA3DQ28082731-5D048CBD-79B4-42EC-A616-BEFCD27C5CD5Q28235095-78C0E121-5AB6-4921-966E-8A966CF2D986Q28262790-0C306CA0-39E6-4994-894B-4B8E8DC7CD6DQ28384795-C7E35824-5121-4EA5-9861-A6A16F6335CDQ28395381-92EA1783-5A4B-4079-A16C-9EBF9F3C2FD7Q28395425-92A16215-B224-44A4-98A9-553A21309977Q28395611-2AF684A7-0ED3-4C44-B202-398166EF8C87Q28397746-B5D32239-337A-4839-A77F-D1D0C0367E13Q28484243-61EFAB5B-98AD-485D-B839-ECB677893982Q28485429-B1DCF2F2-B1DC-4417-BA8A-A983E8410ACAQ28546694-34917063-1EC9-440E-8190-009C1B60904DQ28555082-27142FC8-76C0-4D5F-BDDE-F7B365285855Q28681408-1FBB2A4F-8D26-42F5-8024-6C75A6BDCEB6
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Bacteriophage therapy
@ast
Bacteriophage therapy
@en
Bacteriophage therapy
@nl
type
label
Bacteriophage therapy
@ast
Bacteriophage therapy
@en
Bacteriophage therapy
@nl
prefLabel
Bacteriophage therapy
@ast
Bacteriophage therapy
@en
Bacteriophage therapy
@nl
P2093
P2860
P3181
P1476
Bacteriophage therapy
@en
P2093
A Sulakvelidze
J G Morris
Z Alavidze
P2860
P304
P3181
P356
10.1128/AAC.45.3.649-659.2001
P407
P577
2001-03-01T00:00:00Z